BlackRock
BIOA

BlackRock’s BioAge Labs BIOA Stock Holding History

BlackRock’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.8M Buy
2,849,077
+581,321
+26% +$10.5M ﹤0.01% 2455
2026
Q1 		$39.7M Buy
2,267,756
+740,215
+48% +$14.3M ﹤0.01% 2664
2025
Q4 		$20.2M Buy
1,527,541
+247,920
+19% +$2.2M ﹤0.01% 3104
2025
Q3 		$7.52M Sell
1,279,621
-7,796
-0.6% -$36.5K ﹤0.01% 3590
2025
Q2 		$5.32M Buy
1,287,417
+571,576
+80% +$2.3M ﹤0.01% 3746
2025
Q1 		$2.69M Buy
715,841
+3,447
+0.5% +$15.9K ﹤0.01% 3901
2024
Q4 		$4.12M Buy
+712,394
New +$12.3M ﹤0.01% 3804

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

BlackRock's BIOA Position: Q2 2026 in Review

BlackRock increased its BioAge Labs (BIOA) stake by 26% in Q2 2026, buying an estimated $10.5M and bringing the position to 2,849,077 shares worth $69.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2455.

BlackRock first reported a position in BIOA in Q4 2024 and has held it in 7 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • BlackRock held 2,849,077 shares of BioAge Labs worth $69.8M as of Q2 2026.
  • BlackRock bought 581,321 BioAge Labs shares in Q2 2026, an estimated $10.5M.
  • BioAge Labs made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2455 holding.
  • BlackRock first reported a position in BioAge Labs in Q4 2024 and has held it in 7 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.